Moreover, the SNA display polyvalent interactions and have been claimed to be able to cross the blood–brain barrier, enabling delivery of siRNA to glioblastoma lesions and knockdown of Bcl2L12, promoting apoptosis and tumor shrinkage [35]. The gene discussed is BCL2L12; the disease is neoplasm.